Simultaneous targeted alteration of the tyrosinase and c-kit genes by single stranded oligonucleotides

Gene Therapy

Volumn 9, Issue 24, 2002, Pages 1667-1675

  Alexeev, V ^a   Igoucheva, O ^a   Yoon, K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Albino melanocytes; c kit; Gene alteration; Single stranded oligonucleotides; Tyrosinase

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TYROSINE;

ANIMAL CELL; CHIMERA; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GENE TARGETING; MELANOCYTE; MOUSE; NONHUMAN; PIGMENT CELL; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA, SINGLE-STRANDED; GENE TARGETING; MELANOCYTES; MICE; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; OLIGONUCLEOTIDES; PIEBALDISM; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEINS C-KIT; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

ANIMALIA; MAMMALIA;

EID: 0036953421     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301862     Document Type: Review

References (33)

1. Alexeev V, Yoon K. Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 1998; 16: 1343-1346.
2. Igoucheva O, Peritz AE, Levy D, Yoon K. A sequence-specific gene correction by an RNA-DNA oligonucleotide in mammalian cells characterized by transfection and nuclear extract using a lacZ shuttle system. Gene Ther 1999; 6: 1960-1971.
3. Igoucheva O, Alexeev V, Yoon K. Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Ther 2001; 8: 391-399.
4. Halaban R, Moellmann G. White mutants in mice shedding light on humans. J Invest Dermatol 1993; 100(2 Suppl): 176S-185S.
5. del Marmol V, Beermann F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett 1996; 381:165-168.
6. Shibahara S et al. A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine-serine substitution at position 85. Eur J Biochem 1990; 189: 455-461.
7. Beermann F et al. Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J 1990; 9: 2819-2826.
8. Tanaka S, Yamamoto H, Takeuchi S, Takeuchi T. Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development 1990; 108: 223-227.
9. Huszar D et al. Generation of pigmented stripes in albino mice by retroviral marking of neural crest melanoblasts. Development 1991; 113: 653-660.
10. Jackson IJ, Bennett DC. Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant. Proc Natl Acad Sci USA 1990; 87: 7010-7014.
11. Alexeev V et al. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nat Biotechnol 2000; 18: 43-47.
12. Botchkareva NV et al. SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J 2001; 15: 645-658.
13. Mackenzie MA, Jordan SA, Budd PS, Jackson IJ. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev Biol 1997; 192: 99-107.
14. Yoshida H et al. Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns. Development 1996; 122: 1207-1214.
15. Spritz RA et al. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet 1992; 51: 1058-1065.
16. Spritz RA, Giebel LB, Holmes SA. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 1992; 50: 261-269.
17. Spritz RA. Molecular basis of human piebaldism. J Invest Dermatol 1994; 103: 137S-140S.
18. Nagata H et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560-10564.
19. Longley BJ et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999; 96: 1609-1614.
20. Tsujimura T et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994; 83: 2619-2626.
21. Piao X, Bernstein A. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 1996; 87: 3117-3123.
22. Halaban R et al. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 1992; 12: 154-161.
23. Huang S et al. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 1998; 17: 4358-4369.
24. Zakut R et al. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 1993; 8: 2221-2229.
25. Huang S et al. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their turnorigenic and metastatic potential. Oncogene 1996; 13: 2339-2347.
26. Bar-Eli M. Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res 2001; 14: 78-85.
27. Alexeev V, Yoon K. Gene correction by RNA-DNA oligonucleotides. Pigment Cell Res 2000; 13: 72-79.
28. Capecchi MR. Altering genome by homologous recombination. Science 1989; 224: 1288-1292.
29. Spritz RA, Ho L, Strunk KM. Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting W. J Invest Dermatol 1994; 103: 148-150.
30. Hou L, Panthier JJ, Arnheiter H. Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development 2000; 127: 5379-5389.
31. Bennett DC et al. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 1998; 105: 379-385.
32. Igoucheva O, Yoon K. Improvement of RNA-DNA oligonucleotide design by using mammalian nuclear extracts. Gene Ther Regul 2000; 1: 165-177.
33. Tagalakis AD et al. Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J Biol Chem 2001; 276: 13226-13230.